Dentine Caries Clinical Trial
Official title:
In Vivo Evaluation of the Antimicrobial Activity of Diamine Silver Fluoride and Potassium Iodide on Dentin Carious Lesions in Kuwaiti Subjects.
Dental caries is an infectious disease mediated by a consortium of microbes in the oral cavity. The disease is characterized by demineralization of the tooth, if untreated, it leads to cavitation, discomfort, pain and eventual tooth loss. Frequently, complete caries removal of dentine carious lesions leads to exposure of the pulp affecting its vitality. Therefore, it is crucial that vitality of the teeth is preserved causing little damage to the pulp. Different approaches have been used to reduce or eliminate microorganisms underneath the restorations. Chlorhexidine has a strong antibacterial effect, particularly on planktonic bacteria. Its effect on bacterial biofilms is compromised, however The objective of this study is to examine the in vivo effect of diamine silver fluoride, potassium iodide and their mixture on bacteria present in deep carious lesions. Dentine samples from 5 carious lesions from each of 5 patients before and after treatment with test agents will be collected in pre-reduced sterile Ringer's solution and processed for microbiological evaluation. The samples after serial dilution and plating will be incubated in aerobic, anaerobic and CO2 atmosphere for 2-5 days. Colony forming units will be enumerated and the effect of antibacterial agents in question on the bacterial viability in carious lesions will be assessed.
Study subjects:
Study subjects (n=5) will be recruited from the pool of patients attending Kuwait University
Dental Clinic. Informed written consent will be obtained from all subjects. An approval for
using human subjects in the study will be obtained from the Ethics Committee of HSC, Kuwait
University.
Inclusion criteria:
- Patient is able to give informed consent
- Tooth with moderate size caries lesions, penetrate through ½ of dentine thickness
- Suitable for the placement of a Vitrabond lining
- Restoration is part of a current and approved treatment plan
Exclusion criteria:
- Patient is unable to give informed consent
- Teeth had received temporary restoration
- Isolation with rubber dam is not possible
- Cavity preparation was contaminated due to gingival bleeding
Clinical protocol The cavity will be restored using materials and methods which has been
approved by KUDC, the use of Vitrabond liner is essential as part of this study.
Sample collection: Decayed dentine will be removed by using a sterile dental excavator and
collected into a sterile microfuge tubes for microbiological analyses before treatment.
Using a dental three-in-one air syringe, the tooth surface will then be cleaned using
sterile distilled water and dried for 4 sec. The lesions will be treated with Silver diamine
fluoride, potassium iodide or their mixture (SDI Ltd., Melbourne, Australia), a product made
of silver diamine fluoride (38% w/v) and a saturated solution of potassium iodide and an
oxalic acid based product which contains oxalic acid, potassium salt and water. In parallel,
Chlorhexidine and sterile saline will be used as control treatment agents. After treatment,
dentin samples will be collected using a sterile dental excavator. Followed by excavation,
all three treatment agents will be applied for 30 sec and samples will be collected once
again after the treatment.
Microbiological analysis: The samples after collection will be immediately placed on ice and
brought within 30 min to the Oral Microbiology lab at the Faculty of Dentistry. Standard
protocols will be followed for microbiological culture. Samples collected in pre-weighed
sterile microfuge tubes will be weighed again to determine weight of the dentine material.
Dentin samples will then be suspended in sterile pre-reduced Ringer's solution.. After
vigorously vortexing for 1 min at maximal setting, samples will be 10-fold serially diluted
up to 10-6 in Ringer's solution. Initially in pilot experiments, samples will be cultured on
different media in CO2, aerobic and anaerobic conditions. One hundred microliter from each
dilution will be spread in two sets in duplicate on the following media and incubated:
1. Brucella agar plates supplemented with 5% sheep blood for total viable bacterial count.
Plates will then be incubated in 5% CO2 and anaerobic atmosphere (85% Nitrogen, 10%
Hydrogen and 5% CO2) at 37 C for 2 days. Anaerobic condition in the jars will be
monitored using RT Anaero-Indicator (Mitsubishi Gas Chemical Company Inc., Japan).
2. Mitis salivarius agar (Difco) for Streptococcus spp. count; incubation in 5% CO2 in air
at 37 C for 2 days.
3. Mitis salivarius agar supplemented with 20% sucrose, bacitracin (0.2 units/ml) and 1%
potassium tellurite for Streptococcus mutans count; incubation at 37 C in 5% CO2 in air
for 2 days.
After incubation plates will be removed from the jars and colony forming units (CFU) will be
enumerated from appropriate dilutions. CFUs will be calculated per milligram of the sample
taken . All experiments will be performed in triplicate.
Statistical analysis:
At least three independent experiments, each sample run in duplicates, will be performed.
ANOVA will be used for comparing bacterial counts before and after the application of the
treatment agent. testing the effect of the treatment agent. Mann-Whitney U test will be used
to compare CFU counts between test and control groups. A p value of less than 0.05 will be
considered statistically significant.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04807244 -
Treatment of Deep Carious Lesions With Selective Caries Removal, Partial or Full Pulpotomy
|
N/A |